A
Ashirbani Saha
Researcher at Duke University
Publications - 71
Citations - 2069
Ashirbani Saha is an academic researcher from Duke University. The author has contributed to research in topics: Breast cancer & Breast MRI. The author has an hindex of 20, co-authored 66 publications receiving 1229 citations. Previous affiliations of Ashirbani Saha include St. Michael's Hospital & University of Windsor.
Papers
More filters
Journal ArticleDOI
Deep learning in radiology: An overview of the concepts and a survey of the state of the art with focus on MRI.
TL;DR: Deep learning is a branch of artificial intelligence where networks of simple interconnected units are used to extract patterns from data in order to solve complex problems as mentioned in this paper, and it has shown promising performance in a variety of sophisticated tasks, especially those related to images.
Posted Content
Deep learning in radiology: an overview of the concepts and a survey of the state of the art.
TL;DR: The general context of radiology and opportunities for application of deep‐learning algorithms and basic concepts of deep learning are discussed, including convolutional neural networks and a survey of the research in deep learning applied to radiology are presented.
Journal ArticleDOI
Association of genomic subtypes of lower-grade gliomas with shape features automatically extracted by a deep learning algorithm.
TL;DR: In this paper, the authors proposed a fully automatic way to quantify tumor imaging characteristics using deep learning-based segmentation and test whether these characteristics are predictive of tumor genomic subtypes.
Journal ArticleDOI
Deep learning for segmentation of brain tumors: Impact of cross-institutional training and testing.
TL;DR: There is a very strong effect of selecting data for training on performance of CNNs in a multi-institutional setting, and the reasons behind this effect requires additional comprehensive investigation.
Journal ArticleDOI
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
Elizabeth Hope Cain,Ashirbani Saha,Michael R. Harowicz,Michael R. Harowicz,Jeffrey R. Marks,P. Kelly Marcom,Maciej A. Mazurowski +6 more
TL;DR: The multivariate models based on pre-treatment MRI features were able to predict pathologic complete response (pCR) to neoadjuvant therapy (NAT) in TN/HER2+ patients.